← Leaderboards
Yu-Ning Wong
Fox Chase Cancer Center
$826,451
Attributed
$826,451
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $251.4K · FY2008–12$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$826,451 · 1
By mechanism
K07$826,451 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Deductibles”
- James Franklin Wharam · Harvard Pilgrim Health Care, Inc.$11,038,428
- Colleen L Barry · Yale University$3,969,697
- Sebastian G. Schneeweiss · Brigham And Women'S Hospital$3,488,444
- A Aria Tzika · Massachusetts General Hospital$3,392,068
- Dennis Ross-Degnan · Harvard Pilgrim Health Care, Inc.$3,372,063
- Jeanne Mandelblatt · Georgetown University$3,201,545
Research focus
DeductiblesAffectAdoptionAdherence (Attribute)Antineoplastic AgentsAprepitantBaseBiometryCancer CareAntiemeticsCancer TherapyCareerCaringCharacteristicsChemotherapyChronically IllClinical MedicineClinical ResearchCostCost ControlCost SharingCancer PatientDecision MakingDesign
Grant awards (6)
Clinical and Social Implications of Cost Sharing for Cancer Drugs$144,018
K07 · FY2012 · CA · contact PI
Clinical and Social Implications of Cost Sharing for Cancer Drugs$144,018
K07 · FY2011 · CA · contact PI
Clinical and Social Implications of Cost Sharing for Cancer Drugs$143,678
K07 · FY2010 · CA · contact PI
Clinical and Social Implications of Cost Sharing for Cancer Drugs$143,359
K07 · FY2009 · CA · contact PI
Clinical and Social Implications of Cost Sharing for Cancer Drugs$108,000
K07 · FY2009 · CA · contact PI
Clinical and Social Implications of Cost Sharing for Cancer Drugs$143,378
K07 · FY2008 · CA · contact PI